|
C15ORF33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6107783429884E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0766999514189E-09 |
| Normal-vs-Stage2 |
2.20639995163197E-09 |
| Normal-vs-Stage3 |
2.56049959013183E-10 |
| Normal-vs-Stage4 |
2.60830000042844E-07 |
| Stage1-vs-Stage2 |
1.877960E-01 |
| Stage1-vs-Stage3 |
9.240400E-02 |
| Stage1-vs-Stage4 |
3.081000E-01 |
| Stage2-vs-Stage3 |
5.619000E-01 |
| Stage2-vs-Stage4 |
6.501000E-01 |
| Stage3-vs-Stage4 |
9.323200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0816003648273E-10 |
| Normal-vs-AfricanAmerican |
1.3988810110277E-13 |
| Normal-vs-Asian |
3.72840000000263E-05 |
| Caucasian-vs-AfricanAmerican |
1.662450E-01 |
| Caucasian-vs-Asian |
2.964400E-01 |
| AfricanAmerican-vs-Asian |
3.870800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33868480137289E-12 |
| Normal-vs-Female |
1.98320000421859E-08 |
| Male-vs-Female |
8.540400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.51819667948416E-11 |
| Normal-vs-Extreme_Weight |
5.52400003517306E-09 |
| Normal-vs-Obese |
6.93980000132655E-08 |
| Normal-vs-Extreme_Obese |
4.587300E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.091200E-01 |
| Normal_Weight-vs-Obese |
6.910100E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.401400E-01 |
| Extreme_Weight-vs-Obese |
5.310400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.091200E-01 |
| Obese-vs-Extreme_Obese |
9.534200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.15680001320374E-09 |
| Normal-vs-Age(41-60Yrs) |
1.56270000273295E-08 |
| Normal-vs-Age(61-80Yrs) |
6.69464483848969E-13 |
| Normal-vs-Age(81-100Yrs) |
1.73093999999985E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.183600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.786000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.362170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.195600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.081400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.98220001207994E-09 |
| Normal-VS-Type2 PRCC |
5.40123501480139E-13 |
| Normal-VS-KIRP CIMP |
5.320200000547E-07 |
| Normal-VS-Unclassified PRCC |
9.93930493464745E-11 |
| Type1 PRCC-VS-Type2 PRCC |
1.205760E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.694580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.645800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.416200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.199400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.676800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-15 |
| Normal-vs-N1 |
4.89790430435733E-11 |
| Normal-vs-N2 |
1.05849995435392E-10 |
| N0-vs-N1 |
8.550200E-01 |
| N0-vs-N2 |
3.460200E-01 |
| N1-vs-N2 |
3.429400E-01 |
|
|
